Precision Medicine in AD: Castle Biosciences’ Pipeline AD Test Aims to Change the Way Your Patients Are Treated October 25, 2025
Fall Clinical 2025 News: Roflumilast Cream Improves Sleep in AD Patients and Their Family Members October 24, 2025
‘One Small Step Closer to an AD Cure’: What Eight-week Maintenance Dosing With Lebrikizumab Means for Eczema Patients and Providers October 24, 2025
Rebalancing T Cells in AD: A Conversation With Dr. Emma Guttman-Yassky on Rocatinlimab’s Potential October 10, 2025
Register Now: Inaugural H&W Global Dermatology CME Conference to Address Global Burden of Eczema October 9, 2025
TDD Expert Reaction: U.S. FDA Approves Roflumilast Cream 0.05% for AD in Kids Aged 2 to 5 Featuring Dr. Lawrence Eichenfield October 8, 2025